Magnetic Resonance Imaging Biomarkers for the Early Diagnosis of Alzheimer's Disease: a Machine Learning Approach

Overview

Journal Front Neurosci

Date 2015 Sep 22

PMID 26388719

Citations 86

Authors

Christian Salvatore

Antonio Cerasa

Petronilla Battista

Maria C Gilardi

Aldo Quattrone

Isabella Castiglioni

Affiliations

Soon will be listed here.

Abstract

Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as to lessen the time and cost of clinical trials. Magnetic Resonance (MR)-related biomarkers have been recently identified by the use of machine learning methods for the in vivo differential diagnosis of AD. However, the vast majority of neuroimaging papers investigating this topic are focused on the difference between AD and patients with mild cognitive impairment (MCI), not considering the impact of MCI patients who will (MCIc) or not convert (MCInc) to AD. Morphological T1-weighted MRIs of 137 AD, 76 MCIc, 134 MCInc, and 162 healthy controls (CN) selected from the Alzheimer's disease neuroimaging initiative (ADNI) cohort, were used by an optimized machine learning algorithm. Voxels influencing the classification between these AD-related pre-clinical phases involved hippocampus, entorhinal cortex, basal ganglia, gyrus rectus, precuneus, and cerebellum, all critical regions known to be strongly involved in the pathophysiological mechanisms of AD. Classification accuracy was 76% AD vs. CN, 72% MCIc vs. CN, 66% MCIc vs. MCInc (nested 20-fold cross validation). Our data encourage the application of computer-based diagnosis in clinical practice of AD opening new prospective in the early management of AD patients.

Citing Articles

Machine Learning Approaches for Predicting Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment.

Gelir F, Akan T, Alp S, Gecili E, Bhuiyan M, Disbrow E J Med Biol Eng. 2025; 45(1):63-83.

PMID: 40046733 PMC: 11876274. DOI: 10.1007/s40846-024-00918-z.

Synthetic data analysis for early detection of Alzheimer progression through machine learning algorithms.

Sanchez Reyna A, Mendoza-Gonzalez R, Luna-Garcia H, Celaya Padilla J, Morgan Benita J, Espino-Salinas C PeerJ Comput Sci. 2025; 10:e2437.

PMID: 39896407 PMC: 11784714. DOI: 10.7717/peerj-cs.2437.

A machine learning approach for identifying anatomical biomarkers of early mild cognitive impairment.

Ahmad A, Sanchez-Bornot J, Sotero R, Coyle D, Idris Z, Faye I PeerJ. 2024; 12:e18490.

PMID: 39686993 PMC: 11648692. DOI: 10.7717/peerj.18490.

MRI-Driven Alzheimer's Disease Diagnosis Using Deep Network Fusion and Optimal Selection of Feature.

Ali M, Hussain S, Khalid M, Farrash M, Lahza H, Zafar A Bioengineering (Basel). 2024; 11(11).

PMID: 39593736 PMC: 11591117. DOI: 10.3390/bioengineering11111076.

Novel hippocampus-centered methodology for informative instance selection in Alzheimer's disease data.

Castro-Silva J, Moreno-Garcia M, Guachi-Guachi L, Peluffo-Ordonez D Heliyon. 2024; 10(19):e37552.

PMID: 39381107 PMC: 11456841. DOI: 10.1016/j.heliyon.2024.e37552.

References

Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M . Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol. 2006; 59(4):673-81. DOI: 10.1002/ana.20799. View

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehericy S, Habert M . Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage. 2010; 56(2):766-81. DOI: 10.1016/j.neuroimage.2010.06.013. View

Li Q, Van Antwerp D, Mercurio F, Lee K, Verma I . Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 1999; 284(5412):321-5. DOI: 10.1126/science.284.5412.321. View

Thomann P, Schlafer C, Seidl U, Santos V, Essig M, Schroder J . The cerebellum in mild cognitive impairment and Alzheimer's disease - a structural MRI study. J Psychiatr Res. 2008; 42(14):1198-202. DOI: 10.1016/j.jpsychires.2007.12.002. View

Hidalgo-Munoz A, Ramirez J, Gorriz J, Padilla P . Regions of interest computed by SVM wrapped method for Alzheimer's disease examination from segmented MRI. Front Aging Neurosci. 2014; 6:20. PMC: 3929832. DOI: 10.3389/fnagi.2014.00020. View

Ishii K, Kawachi T, Sasaki H, Kono A, Fukuda T, Kojima Y . Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am J Neuroradiol. 2005; 26(2):333-40. PMC: 7974092. View

Moradi E, Pepe A, Gaser C, Huttunen H, Tohka J . Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage. 2014; 104:398-412. PMC: 5957071. DOI: 10.1016/j.neuroimage.2014.10.002. View

Gerardin E, Chetelat G, Chupin M, Cuingnet R, Desgranges B, Kim H . Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage. 2009; 47(4):1476-86. PMC: 3001345. DOI: 10.1016/j.neuroimage.2009.05.036. View

Focke N, Helms G, Scheewe S, Pantel P, Bachmann C, Dechent P . Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls. Hum Brain Mapp. 2011; 32(11):1905-15. PMC: 6870106. DOI: 10.1002/hbm.21161. View

10.

Kloppel S, Stonnington C, Chu C, Draganski B, Scahill R, Rohrer J . Automatic classification of MR scans in Alzheimer's disease. Brain. 2008; 131(Pt 3):681-9. PMC: 2579744. DOI: 10.1093/brain/awm319. View

11.

Fox N, Schott J . Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet. 2004; 363(9406):392-4. DOI: 10.1016/S0140-6736(04)15441-X. View

12.

Karas G, Burton E, Rombouts S, van Schijndel R, OBrien J, Scheltens P . A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage. 2003; 18(4):895-907. DOI: 10.1016/s1053-8119(03)00041-7. View

13.

Choi S, Park J, Chung J, Yoo T, Kim D . Multicategory classification of 11 neuromuscular diseases based on microarray data using support vector machine. Annu Int Conf IEEE Eng Med Biol Soc. 2015; 2014:3460-3. DOI: 10.1109/EMBC.2014.6944367. View

14.

Knopman D, DeKosky S, Cummings J, Chui H, Corey-Bloom J, Relkin N . Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56(9):1143-53. DOI: 10.1212/wnl.56.9.1143. View

15.

Mitchell A, Shiri-Feshki M . Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009; 119(4):252-65. DOI: 10.1111/j.1600-0447.2008.01326.x. View

16.

Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland N . Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis. 2002; 10(2):128-38. DOI: 10.1006/nbdi.2002.0498. View

17.

Morris J . The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11):2412-4. DOI: 10.1212/wnl.43.11.2412-a. View

18.

Petersen R, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56(3):303-8. DOI: 10.1001/archneur.56.3.303. View

19.

Grabner G, Janke A, Budge M, Smith D, Pruessner J, Collins D . Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. Med Image Comput Comput Assist Interv. 2007; 9(Pt 2):58-66. DOI: 10.1007/11866763_8. View

20.

Habeck C, Foster N, Perneczky R, Kurz A, Alexopoulos P, Koeppe R . Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage. 2008; 40(4):1503-15. PMC: 2441445. DOI: 10.1016/j.neuroimage.2008.01.056. View